Skip to Main Content Menu Search Search Sign In Quick Links News Sports Radio Music Listen Live TV Watch COVID-19 Local updates Watch live COVID-19 tracker Vaccine tracker Top Stories Local The National Opinion World Canada Politics Indigenous Business Health Entertainment Tech & Science CBC News Investigates Go Public Shows About CBC News Business CanniMed seeks regulatory action against Aurora's hostile takeover bid CanniMed Therapeutics says it is seeking regulatory action in both Saskatchewan and Ontario in its latest push back against Aurora Cannabis' hostile takeover bid. Social Sharing CanniMed seeking order that Aurora's hostile offer be considered an 'insider bid' The Canadian Press · Posted: Dec 11, 2017 10:59 AM ET | Last Updated: December 11, 2017 CanniMed Therapeutics is trying to fend off a hostile takeover bid from Aurora Cannabis. (Jim Mone/Associated Press) CanniMed Therapeutics is seeking regulatory action in both Saskatchewan and Ontario, the company's latest push back against a hostile takeover attempt by Aurora Cannabis. The Saskatoon-based medical marijuana producer said Monday it has applied to securities regulators in both provinces for several orders, including that Aurora's hostile offer be considered an "insider bid," and be treated as such. CanniMed adopts shareholder rights plan in takeover fight with Aurora Cannabis Canadian pot startups are growing up — and shacking up ?Among other things, CanniMed is asking regulators to cease Aurora's takeover bid until 105 days after a circular that meets the regulatory requirements of an insider bid. The announcement was made shortly before the Ontario Securities Commission's scheduled hearing on a related matter brought to it by Aurora, which asked the OSC to block CanniMed's takeover defence, or shareholders rights plan. Last month, Aurora launched an all-stock hostile takeover bid for CanniMed, with one of its conditions being that CanniMed abandon its own proposed acquisition of Newstrike Resources Ltd. Aurora takeover bid 'makes no sense,' based on inflated share price: CanniMed CanniMed tells shareholders to wait while it reviews Aurora offer CanniMed has argued that Aurora's offer does not make sense for shareholders, but its own bid to acquire the Tragically Hip-backed marijuana company does. The Saskatoon-based marijuana company asked Monday for regulators require Aurora to retract and correct what it says are "several materially false and misleading statements" in connection with its hostile bid. CBC's Journalistic Standards and Practices|About CBC NewsReport Typo or Error Related Stories CanniMed adopts shareholder rights plan in takeover fight with Aurora Cannabis Analysis Merger madness: Canada's marijuana industry enters consolidation phase Aurora takeover bid 'makes no sense,' based on inflated share price: CanniMed CanniMed tells shareholders to wait while it reviews Aurora offer Footer Links My Account Profile CBC Gem Newsletters About CBC Membership Connect with CBC Facebook Twitter YouTube Instagram Mobile RSS Podcasts Contact CBC Submit Feedback Help Centre Audience Relations, CBC P.O. Box 500 Station A Toronto, ON Canada, M5W 1E6 Toll-free (Canada only): 1-866-306-4636 TTY/Teletype writer: 1-866-220-6045 About CBC Corporate Info Sitemap Reuse & Permission Terms of Use Privacy Jobs Our Unions Independent Producers Political Ads Registry AdChoices Services Ombudsman Corrections and Clarifications Public Appearances Commercial Services CBC Shop Doing Business with Us Renting Facilities Accessibility It is a priority for CBC to create a website that is accessible to all Canadians including people with visual, hearing, motor and cognitive challenges. Closed Captioning and Described Video is available for many CBC shows offered on CBC Gem. About CBC Accessibility Accessibility Feedback ©2021 CBC/Radio-Canada. All rights reserved. Visitez Radio-Canada.ca now